SPC 3.
D019380:Anti-HIV Agents / Q000378:metabolism / Q000494:pharmacology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D015507:Drugs, Investigational / Q000378:metabolism / Q000494:pharmacology*; D015699:HIV Envelope Protein gp120 / Q000378:metabolism / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects; D015498:HIV-2 / Q000187:drug effects; D006801:Humans; D010446:Peptide Fragments / Q000378:metabolism / Q000494:pharmacology*; D011994:Recombinant Proteins
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D015699:HIV Envelope Protein gp120; D010446:Peptide Fragments; D011994:Recombinant Proteins; C098257:SPC3 peptide